BBMRI.at comprises the Medical Universities of Graz, Vienna, Innsbruck, the JKU Linz Medical Faculty and the University of Veterinary Medicine with their biobanks. The University of Vienna brings in legal expertise. BBMRI.at develops the Austrian biobanking research infrastructure and links it to the European community. Focus is to increase close cooperation and harmonisation between biobanks and foster research collaborations using samples/data and expertise.
BBMRI.at partners harbour 22+ million human and animal samples with associated data to support academic and industrial research. BBMRI.at was established in 2013 and is funded by the Federal Ministry of Education, Economy and Research. More about BBMRI.at.
Top 3 Areas of expertise
- Quality & data management: Developing/implementing ISO/CEN (pre-analytics) standards; QM cross-audits; Training/webinars; High-capacity tissue slide digitalisation (whole-slide-imaging) & AI; Bio bank-Editor; Trusted data environment/access model; Data quality; BSL-3 facility & high-risk pathogen-containing material.
- Stakeholder & user engagement: BBMRI.at Legal Knowledge-Base & Helpdesk, Public engagement(e.g., Long Night of Research, biobank tours, children’s courses); Education/training (e.g., QM, standards & IVDR; biobanking (MSc, courses)); Industry cooperation.
- Non-human & green biobanking: Veterinary/animal
biobanking for comparative medicine/One-Health;
Green biobanking & environmental sustainability;
Non-human biobanking (QM, ELSI).
Top 3 Achievements
- Harmonisation & standardisation: Leading “ISO 18701 human specimens – microbiome DNA”; ISO 24051-2 “Digital pathology & AI-based image analysis” development; QM cross-audits on ISO-20387; Organising QM course on ISO-21899; Operation of BBMRI.at Legal Helpdesk & Knowledge Base supporting part ners; ELSI harmonisation; Co-leading the Austrian Cohort Initiative as platform for research groups with cohorts.
- Data management: Development of technical specification for BBMRI.at Biobank Data Communication Platform “trusted environment for patient/research data” in EvolveBBMRI; complementing biobank sam ples with digital whole slide images (WSI).
- Stakeholder / user information and engagement: Co-leading 4 strategic objectives of BBMRI-ERIC’s WP25-27; Multiple grants and industry collaborations; Awareness raising on veterinary biobanks’ potential for comparative medicine/One Heath, and on green biobanking; Contribution to SCIBIOEU’s Biobanking Adventure Game and eCourse; Multimedia stories at World Patient Safety Day and One Health Day; Several dissemination and communication; Scientific publica tions with biobank/BBMRI.at contributions.
Achievements linked to calendar year 2025
Biobanks in the Directory 4
Search them in the BBMRI-ERIC Directory →
Contact
Austria node page →
Belgium’s scientific participation in BBMRI-ERIC was initiated in 2013 by merging the three existing Belgian network biobank initiatives. The activities of BBMRI.be are coordinated from the coordination office located at the Belgian Cancer Registry.
All relevant biobank topics are addressed by more than 60 biobank experts in the six working groups of BBMRI.be (IT, ELSI, Quality, Sustainability, Stakeholder Involvement, Networking & Valorisation). The BBMRI.be network currently connects 21 Belgian biobanks linked to public institutions such as hospitals, universities and research centres. More about bbmri.be
Top 3 Areas of expertise
- Clinical biobanks
- Healthcare integrated biobanking
- Quality management of samples and data
Top 3 Achievements
- ISO20387 audit training: In November 2025, BBMRI.be organised a two-day training for biobank staff to become quality auditors for ISO 20387 in collaboration with BBMRI-ERIC
- Validation of the BIOCOST model: The BIOCOST model previously developed within the Sustainability Working Group was validated by nine BBMRI.be biobanks. The results of the validation were written down in a manuscript that was submitted to “Biopreservation and Biobanking”.
- Overarching QM manual: The first version of the overarching QM manual was finalised in collaboration with the National Nodes from Germany, Switzerland and Poland.
Achievements linked to calendar year 2025
Biobanks in the Directory 19
Search them in the BBMRI-ERIC Directory →
Contact
Belgium node page →
BBMRI.bg is based at Molecular Medicine Center, Medical University of Sofia, hosting the biggest national biobank with various clinical and population research collections. The biobanking network involves biobanks from two of the biggest Medical Universities in Sofia and Plovdiv.
BBMRI.bg is supported by the Ministry of Education and Science in the frame of the National Roadmap of Research Infrastructures. The goal of the National Node is to enlarge the biobanking network, increase international visibility and further use of the available collections, supporting high quality technical and ethical standards and contributing to health research and precision medicine. More about BBMRI.bg
Top 3 Areas of expertise
- Research biobanking in cancer and complex diseases, including collection of various biological samples and data for advanced Omics research.
- Clinical biobank for research in rare diseases, linking sample collections from Genome Diagnostics Laboratory with BBMRI.bg.
- Capacity for whole exome and whole genome analysis by NGS and aCGH, coupled with storage at the GDI national hub.
Top 3 Achievements
- Collection of additional 1000 participants for the Genome of Bulgaria as part of the Genome of Europe project, following massive national media campaign.
- Financial support for BBMRI.bg was provided by the Ministry of Education and Science within the framework of the National University Complex for Biomedical and Translational Research (NUCBTR), as a Research Infrastructure on the National Roadmap. This support covers operational costs, biobanking activities for GoE participants, WGS, as well as co-funding of the
GDI project aimed at establishing the Genome Data Hub.
- Cooperation with EATRIS and Health and LifeScience Cluster. Presenting BBMRI.bg and international projects at the meeting „Biomarkers in Translational Medicine — Common Goals and Shared Expertise“, organised by EATRIS Bulgaria, 28.11.2025 in Sofia.
Achievements linked to calendar year 2025
Biobanks in the Directory 1
Search them in the BBMRI-ERIC Directory →
Contact
Bulgaria node page →
BBMRI.cy is the official Cypriot node of BBMRI-ERIC, led by the Ministry of Health and integrating the national biobanking landscape with European standards and infrastructures. The Node encompasses the country’s two biobanks and coordinates national biospecimen and data collections. These include biobank.cy — Centre of Excellence in Biobanking and Biomedical Research at the University of Cyprus — and the Cyprus Institute of Neurology and Genetics (CING), which contributes clinical and disease-focused collections.
BBMRI.cy provides secure, GDPR-compliant access, ELSI support and links Cypriot researchers, clinicians and industry to BBMRI-ERIC’s federated platform, enabling international research access and advancing precision medicine and genomic initiatives in Cyprus. More about BBMRI.cy
Top 3 Areas of expertise
- Population-level genomics and precision medicine, including systematic recruitment and characterisation of the Cypriot population.
- Inherited and rare disorders, with longstanding expertise in kidney diseases and expanding collections in cardiovascular, ophthalmic and other genetic conditions.
- Biobanking-driven translational research, integrating biospecimen collection, clinical data and genomic analysis to support research on complex traits and inherited disorders.
Top 3 Achievements
- Participation in BBMRI-ERIC and EU-level initiatives: Cyprus, as a full member of BBMRI-ERIC, continued participation in coordination activities and contributed to pan-European initiatives including Genome of Europe (GoE), the Global Biodata and Biobanks Initiative (GDI) and EvolveBBMRI.
- National biobanking operations: biobank.cy CoE continued population-level biospecimen and data collection under approved protocols and maintained operational workflows supporting national genomic and precision medicine research activities.
- Node integration of national biobanks: The BBMRI.cy National Node maintained the integration of biobank.cy and the Cyprus Institute of Neurology and Genetics as collaborating biobanks, ensuring national representation within BBMRI-ERIC structures and European access and visibility mechanisms.
Achievements linked to calendar year 2025
Biobanks in the Directory 2
Search them in the BBMRI-ERIC Directory →
Contact
Cyprus node page →
The Network of Czech Biobanks (BBMRI.cz) is the unique national infrastructure in the Czech Republic providing coordinated collection, long-term storage and access to biological samples and associated data for scientific and biomedical research. Established in 2010, BBMRI.cz has developed into a distributed large research infrastructure currently comprising eight biobanks across the country.
The network manages biological material and data from donors with oncological, rheumatological, and hematopoietic disorders, as well as samples from population-based and environmental studies. BBMRI.cz offers a unique combination of advanced technologies, specialised services and expert knowledge, particularly supporting translational research. More about BBMRI.cz
Top 3 Areas of expertise
- Data collections: Intensive data fairification and datafication
of Czech biobanks.
Digital pathology: Use of digital and molecular pathology
in oncology and biobanking- Archived samples: Wide spectrum of biomaterial types including population-based and disease-specific collections and rare diseases.
Top 3 Achievements
- Datafication: All Czech member biobanks have been connected to the BBMRI ERIC Federated Platform, enabling real time discovery of biospecimens and associated clinical (meta)data.
- CS-BIQ project: The project connects the national nodes BBMRI.cz and BBMRI.ch with the aim of strengthening the quality and interoperability of biobanking services in both countries.
- Focus on patient organisations: Assignment of Memorandum of Understanding with Alliance of Women with Breast Cancer, o.p.s., first educational seminar was managed as part of improvement of awareness of biobanks and biobanking.
Achievements linked to calendar year 2025
Biobanks in the Directory 9
Search them in the BBMRI-ERIC Directory →
Contact
Czech Republic node page →
The Danish Biobank Network is a national network that brings together Danish population-based, research and clinical biobanks to support scientific progress. By facilitating Denmark’s participation as an observer in BBMRI, the network enhances international collaboration, linking Danish biobanks with European partners to promote knowledge exchange and joint research efforts. Additionally, the network ensures strong cooperation among Danish biobanks, fostering synergy and coordination across institutions.
The network consists of members from the Danish regions, the Ministry of the Interior and Health, universities with health faculties and the Danish National Biobank, creating a strong foundation for cooperation in biomedical research.
Top 3 Areas of expertise
- Strong Data Foundation: Large population cohorts and high quality disease specific biobanks available for research; Extensive research data; Seamless linkage to national health registries
- Strong national network: National collaboration in a robust and open network
- Extensive experience in providing and utilising biobank data: High trust and support from the citizens; Extensive use of biobank samples; High utilisation of biobank samples in active research
Top 3 Achievements
- Funding has been secured as part of the implementation
of the National Strategy for Personalised Medicine
to support:
- Grants from NordForsk and the Nordic Council of
Ministers have been secured to:
- Enhancing the IT infrastructure and international
interoperability of the Danish Biobank Register:
Achievements linked to calendar year 2025
Contact
Denmark node page →
The Estonian Biobank (EstBB) is a volunteer-based prospective and longitudinal biobank, maintaining and managing the biological samples and healthcare, lifestyle and omics data of 212,000 biobank participants. Available samples include DNA, plasma and buffy coat cells for all participants, and more sample types for smaller subsets. Available data includes periodically updated health records from national healthcare and other relevant registries, genotyping data from Illumina GSA microarrays and metabolomics data from Nightingale Health for all participants. Smaller subsets of participants have WGS (short-read and long-read), gut metagenome sequencing data, clinical biochemistry measurements, RNAseq and other data. More about BBMRI.ee
Top 3 Areas of expertise
- Sample and data collection from biobank participants, including initial recruitment as well as follow-up visits for specific research purposes. Recall studies can be conducted based on specific genetic findings or existing diagnoses.
- Integration of electronic health records from structured data sources and transformation of more detailed free-form medical records into a research-ready format.
- DNA analysis, including long-read whole genome sequencing, genotyping arrays and metagenomic sequencing.
Top 3 Achievements
- A modernised Bill regulating the Estonian Biobank, enabling opt-in transfer of participant data from the biobank to the healthcare system for personalised medicine services, was drafted in cooperation between the Estonian Biobank and the Ministry of Social Affairs and passed to the legislature for deliberations.
- TeamPerMed project started a world-first personalised genetic risk-based study on heart disease prevention using statin therapy. The study involves more than 2500 biobank participants over a 5-year study period.
- Estonian Biobank was included in the Estonian research infrastructure roadmap as part of the Estonian Centre for Genomics. This provides funding to improve and modernise the IT infrastructure and access procedures, upgrade automated sample storage systems and supplement the microbiome dataset at the Estonian Biobank in 2025-2029.
Achievements linked to calendar year 2025
Biobanks in the Directory 7
Search them in the BBMRI-ERIC Directory →
Contact
Estonia node page →
BBMRI.fi is a research infrastructure comprising ten biobanks in Finland. BBMRI.fi is the Finnish National Node of the European level BBMRI-ERIC. The Finnish Biobanks Cooperative – FINBB has coordinated BBMRI.fi since 2020. FINBB was appointed to this role by Ministry of Education and Culture. More at BBMRI.fi
Top 3 Areas of expertise
- National one-stop shop biobank services for researchers through Fingenious® services which includes Availability, Request and Recruit Services.
- High quality sample collections with associated clinical data derived from Electronic Health records (EHRs), as well as study / population cohorts and expert data analysis capabilities.
- Capability and processes to recruit participants to clinical trials and to return biobank study results to participants.
Top 3 Achievements
- Fingenious.fi – the gateway to Finnish biobanks and biomedical research is enhancing international collaboration. Over 2,000 researchers from 45 countries. Over 500 projects conducted and >2000 scientific publications in peer-reviewed journals.
- Large biobank study FinnGen is proceeding as planned. Already >500,000 samples collected and genotyped and proteomics analysis on-going.
- Large-scale biobank infrastructure development project funded by the Finnish Research Council initiated and on-going. The mission is to build world’s most impactful biobank network.
Achievements linked to calendar year 2025
Biobanks in the Directory 11
Search them in the BBMRI-ERIC Directory →
Contact
Finland node page →
The German Biobank Network (GBN) unites academic biobanks at 38 sites that collect human biosamples to make them available for biomedical research across Europe. The network ensures harmonised quality standards and facilitates access to high-quality biospecimens and associated data. Funded through the Network of University Medicine (NUM) by the German Federal Ministry for Research, Technology and Space (BMFTR), GBN serves as Germany’s National Node of BBMRI-ERIC. In July 2025, the former German Biobank Node and the German Biobank Alliance merged under the new name, reflecting GBN’s role as a central infrastructure for university medicine. More about BBMRI.de.
Top 3 Areas of expertise
- Integrated research support: Biobanks provide broad, high-quality bioresources and increasingly support multicentre studies, industry collaborations and translational research.
- Quality management: Germany hosts one of Europe’s strongest biobank quality ecosystems, with multiple DIN EN ISO 20387-accredited biobanks and several recipients of the BBMRI-ERIC Quality Label.
- Public engagement and outreach: GBN biobanks actively engage citizens through open days, science festivals and educational programmes.
Top 3 Achievements
- Strategic integration and consolidation: In 2025, GBN was integrated into the Network of University Medicine (NUM) and consolidated under the name German Biobank Network (GBN), reinforcing its role as a central infrastructure for academic biobanking in Germany.
- Biobank platform initiative: Building on the inclusion of a ‘National Biobank’ in Germany’s coalition agreement, GBN mobilised a broad alliance of academic, political and industry stakeholders and co-developed a national platform concept, positioning the network for major new funding and implementation from 2026 onwards.
- Network growth: GBN expanded its national reach by welcoming new member biobanks in Munich, Ulm and Magdeburg.
Achievements linked to calendar year 2025
Biobanks in the Directory 67
Search them in the BBMRI-ERIC Directory →
Contact
Germany node page →
BBMRI.gr is Greece’s National Node of BBMRI-ERIC and the country’s central hub for biobanking. It integrates high-quality human biological samples with associated clinical and research data, alongside advanced biomolecular technologies, including the Greek Genome Center, from leading hospitals, universities and research centres nationwide.
BBMRI.gr enables biomedical research, precision medicine and innovation by offering harmonised access, strong governance, and comprehensive ethical and legal support. It further leverages artificial intelligence tools for data integration, analysis and interpretation, while providing cutting-edge analytical services and actively linking Greek research with the European Research Area, fostering collaboration, interoperability and scientific excellence. More about BBMRI.gr.
Top 3 Areas of expertise
- High-quality collection, processing and long-term storage of diverse human biospecimens linked to rich clinical, epidemiological and lifestyle data.
- Advanced biomolecular, “omics” profiling (genomics, proteomics, metabolomics), biological and clinical bioimaging supported by robust bioinformatics and AI-driven analytical tools to advance radiogenomics approaches.
- Strong ethical, legal and data-governance frameworks enabling secure, FAIR and responsible access for research and innovation.
Top 3 Achievements
- Submitted New Funding Proposal and One Million Genomes Alignment: In 2025, BBMRI.gr submitted a major national funding proposal aligned with the One Million Genomes initiative, strengthening population-scale genomics, data interoperability and Greece’s contribution to European precision medicine. The proposal integrates the Greek Genome Center and promotes the use of AI tools for largescale data analysis and cross-border research collaboration.
- Expansion of the National Biobanking Network: The BBMRI.gr network expanded through the integration of new hospital- and research-based biobanks, including biobanks of isolated regions, viromes and Alzheimer’s biobanks, increasing geographic coverage, sample diversity and representation of the Greek population under harmonised quality standards.
- Social Science Integration and Governance Strengthening: Collaboration with the National Center for Social Research (EKKE) advanced social science integration, reinforcing ethical governance, public engagement and societal impact assessment.
Achievements linked to calendar year 2025
Biobanks in the Directory 3
Search them in the BBMRI-ERIC Directory →
Contact
Greece node page →
The BBMRI-ERIC Hungarian Biobank Node (HBN) acts as the national umbrella organisation for Hungary’s largest biobanks and represents the Hungarian biomedical research community within BBMRI-ERIC. Established in 2021 with the support of the Hungarian Research and Innovation Office, HBN brings together six major biobanks from leading academic, clinical and industrial institutions and has recently been joined by the Budapest University of Technology and Economics as a new member providing IT service support.
Its mission is to provide ethical, standardised and FAIR-compliant access to high-quality biospecimens and associated clinical data, thereby supporting precision medicine and research innovation. In addition, HBN promotes collaboration, capacity building and infrastructure development, enhancing the national and international visibility and impact of Hungarian biobanks. More about BBMRI.hu.
Top 3 Areas of expertise
- Disease-focused biobanking with rich, longitudinal clinical and molecular datasets, supporting translational and precision medicine research.
- Clinical-trial–ready biobanking and data services, with particular strengths in oncology, rare diseases and cardiovascular disorders.
- High-throughput, quality controlled biospecimen and real-world data generation serving academic and industry partners; several sites actively contribute to real-world evidence initiatives, including the EMA’s DARWIN project.
Top 3 Achievements
- Completion of the Semmelweis Federated Data Warehouse enabling fully operational, secure and FAIR-aligned data sharing among biobank partners, accompanied by the release of an educational YouTube film explaining federated data sharing to researchers and the wider public.
- Initiation of a national biobanking data federation representing a major step toward interoperable, country-wide access to biospecimen-associated data and strengthening coordinated data governance at the national level.
- Strategic expansion toward a One Health approach in biobanking, integrating human, animal and environmental perspectives and incorporating Nagoya Protocol–compliant access and benefit-sharing principles to ensure ethical and legally sound use of non-human genetic resources.
Achievements linked to calendar year 2025
Biobanks in the Directory 5
Search them in the BBMRI-ERIC Directory →
Contact
Hungary node page →
The International Agency for Research on Cancer (IARC) is the specialised cancer research agency of the World Health Organization (WHO). Created in 1965 in Lyon, IARC’s mission is to promote international collaboration in cancer research and understand the causes of cancer. With the support of 27 participating Member States, the Agency makes an exceptional contribution to the fight against cancer worldwide, by mobilising individuals and organisations around common values and objectives.
IARC is interdisciplinary, bringing together skills in epidemiology, laboratory sciences and biostatistics to identify the causes of cancer so that preventive measures may be adopted, and the burden of disease and associated suffering reduced. A significant feature of IARC is its expertise in coordinating research across countries and organisations; its independent role as an international organisation facilitates this activity.
Aligned with its WHO mandate, IARC has a particular interest in conducting research in low and middle-income countries through partnerships and collaborations with researchers in these regions. More about IARC/WHO.
Top 3 Areas of expertise
- Cancer research on an international scale.
- Cancer research in resource-restricted settings and Low-and Middle-Income Countries (LMICs).
- Create and disseminate research-informed national and international guidelines.
Top 3 Achievements
- Supported the launch of major national and regional initiatives, e.g., the Arab Biobank Network and the new Malaysian National Guidelines on the use of Human Biological samples for Research.
- Over 50+ LMIC biobanks from 26 countries have now joined BCNet, creating the largest network of LMICbased biobanks for cancer research.
- Participation in the PERIFORMANCE grant, that will drive forward digital engagement with biobanks.
Achievements linked to calendar year 2025
Contact
IARC/WHO node page →
The Italian Node of BBMRI-ERIC (BBMRI.it), established in 2013, is a distributed infrastructure including 62 qualified biobanks located throughout Italy, the National Institute of Health, the CNR, 19 universities, 33 research hospitals, 45 hospitals, 15 patient associations and a large community of researchers involved in disease-oriented projects that relies on the use of collections of biological resources. A Help Desk and Common Services for ICT, Quality and ELSI have been set up to support the network and >290 research groups and about 1100 users. More about BBMRI.it.
Top 3 Areas of expertise
- Quality Management (QM): QM trainings and support to biobanks. Support to implementation of ISO 20387 Standard. Healthcare integrated biobanking.
- ELSI with a specific focus on co-production of knowledge as well as on stakeholder and user engagement.
- Data management: Secure IT solution for managing big data and sensitive data. Adoption of BBMRI-ERIC standards and development of training and tools to improve interoperability of research databases.
Top 3 Achievements
- Development of a Service Catalogue to provide structured and consistent access to 119 services from 32 providers for sample characterisation and big data production.
- Development of the BBMRI Consent APP, aimed at facilitating interaction between participants and research biobanks through digital consent options based on the CCE, in format compatible with the Federated Platform.
- Collections in the directory have increased to 304 and samples to >3.45M samples. Three biobanks connected to the BBMRI-ERIC federated platform expanded their available interoperable collections to 2500 samples from 800 patients. In 2025, BBMRI.it recorded 103 successful accesses. One additional biobank achieved ISO 20387 accreditation in 2025.
Achievements linked to calendar year 2025
Biobanks in the Directory 64
Search them in the BBMRI-ERIC Directory →
Contact
Italy node page →
The aim of BBMRI.lv is to provide resources for biomedicine research in Latvia and collaborate with institutions abroad, ensuring knowledge circulation, development and setting of new goals, that will encompass international standards, best practices and promote scientific excellence.
Currently, there are four leading biobanking institutions involved in Latvian National Biobank Network — Latvian Biomedical Research and Study centre (National Node/Coordinator), University of Latvia, Riga Stradins University, Riga Children Hospital. BBMRI.lv also maintains close collaboration with other biobanking institutions in the fields of environmental biobanking, aligning with OneHealth initiatives in Latvia. More about BBMRI.lv.
Top 3 Areas of expertise
- Biological samples of population-based and disease-specific collections, survey data and information retrieval from health care system.
- Large-scale sequencing (genome, transcriptome, exome, metagenome) and digitalisation of biological samples in national scale “omics” projects.
- Activities in ELSI and quality management on national and international level.
Top 3 Achievements
- Development of genomic data storage and processing infrastructure in Latvia for Latvian Genome Reference project under the “European Million Genomes Initiative” (1+MG). This will serve as foundation of future personalised medicine development in Latvia.
- Organisation of national-level activities for biobanks and researchers about ELSI, QM and data protection and local level consultations. Promotion of Biobank law for coming in into force in Latvia participation in the working group for development of national regulation for secondary data use for research.
- Participation in the development of more than 20 national-level and more than 10 international-level research projects; proposals include areas of diabetes, tumour research, rare disease, microbiome, omics data, ELSI and other.
Achievements linked to calendar year 2025
Biobanks in the Directory 2
Search them in the BBMRI-ERIC Directory →
Contact
Latvia node page →
The BBMRI.lt node represents the National Cancer Institute of Lithuania (node coordinator), Vilnius University, Vilnius University Hospital Santaros Klinikos, the State Research Institute Centre for Innovative Medicine, the Lithuanian University of Health Sciences and the Hospital of the Lithuanian University of Health Sciences, Kauno Klinikos. Together, biobanks maintain collections covering oncology, haematology, rheumatology, infectious diseases and population-based cohorts.
The collections include snap-frozen and formalin-fixed paraffin-embedded tissues, digital images, blood-derived samples, viable cells, DNA/RNA and associated clinical, demographic and epidemiological data. The infrastructure is being expanded to support multimodal phenotype integration and population-level biomedical research. More about BBMRI.lt.
Top 3 Areas of expertise
- Advanced biorepositories for oncological and other diseases, applying cutting-edge freezing and storage technologies to preserve high-quality tissues, cells and 3D cell cultures for use in advanced in vitro models.
- Application of next-generation sequencing (NGS) and data science approaches to explore complex diseases and population-level health questions.
- High-capacity digitalisation of pathology data, including whole slide imaging (WSI) and AI-based analytical solutions.
Top 3 Achievements
- BBMRI.lt hosted the first Lithuanian National Biobanking Forum, strengthening collaboration among biobanks, researchers, healthcare institutions and the public.
- Following a national infrastructure modernisation project, all Lithuanian biobanks were licensed, became fully operational and advanced digital transformation through paperless workflows and the implementation of electronic informed consent.
- The Lithuanian Population and the Rare Disorders Biobank launched a participant engagement platform, implemented a structured data quality model and joined the BBMRI-ERIC Directory, enhancing international visibility and accessibility for research collaborations.
Achievements linked to calendar year 2025
Biobanks in the Directory 4
Search them in the BBMRI-ERIC Directory →
Contact
Lithuania node page →
Malta’s BBMRI-ERIC National Node represents DwarnaBio, the national population genomic biobank initiative led by the University of Malta. The node’s role is to develop a BBMRI-aligned, quality-managed biobanking platform that supports recruitment of a representative cohort, standardised biospecimen processing and storage, secure pseudonymisation and data governance and ethically robust participant engagement through dynamic consent.
The node is progressing national partnerships, including alignment with 1+MG activities, to strengthen interoperability and enable research that improves genomic discovery and clinical interpretation in the Maltese population. More about BBMRI.mt.
Top 3 Areas of expertise
- Population genomics and variant interpretation: Building Maltese reference resources to improve rare-variant classification and reduce VUS burden, with linkage to phenotype and longitudinal follow-up.
- Biobank operations and quality management: Standardised SOPs for blood processing, aliquoting, traceable sample management and pre-analytical quality control.
- ELSI and dynamic consent: participant-centred governance, recontact capability, and ethically robust approaches to data sharing and return of findings.
Top 3 Achievements
- Strategic sustainability and scale-up: We developed and submitted the University of Malta MALGENPOP grant application to establish a coordinated population genomics research cluster and underpin a fiveyear growth plan for DwarnaBio operations and downstream science.
- National genomics delivery: We completed the first 200 whole-genome sequences within Malta’s 1+MGlinked programme, establishing a tangible national WGS capability and a foundation for Maltese reference data generation.
- Public trust and recruitment: We expanded community outreach through targeted engagement and awareness activities to improve genomic literacy, support participation and strengthen the dynamic-consent model that enables long-term recontact and governance.
Achievements linked to calendar year 2025
Biobanks in the Directory 1
Search them in the BBMRI-ERIC Directory →
Contact
Malta node page →
The Montenegro National Node is a newly established national framework aimed at connecting existing biological sample collections and relevant expertise across research and healthcare institutions in Montenegro.
As a new BBMRI-ERIC National Node, its initial focus is on mapping existing resources, building a national biobanking network and progressively aligning practices with BBMRI-ERIC standards in quality management, ELSI and data management. The Node aims to facilitate responsible use of biological samples and associated data and strengthen national and international collaboration in biomedical research.
Top 3 Areas of expertise
- Clinical and translational biomedical research: Research involving human biological samples and associated clinical and laboratory data, with particular experience in molecular oncology and biomarker research.
- Pathology and molecular medicine: Expertise in tissue-based research, molecular diagnostics and molecular characterisation of human disease.
- Clinically characterised biological sample collections: Experience in establishing and using research collections of human biological samples linked to relevant clinical, pathological and laboratory information.
Top 3 Achievements
- Montenegro became an Observer of BBMRI-ERIC in 2026: Montenegro was formally admitted as an Observer of BBMRI-ERIC in June 2026, marking the beginning of its integration into the European biobanking research infrastructure.
- Establishment of the Montenegro National Node: The Montenegro National Node was established as the national coordination point for the development of biobanking activities and cooperation with BBMRI-ERIC.
- Initiation of national mapping of biobanking resources: Mapping of existing biological sample collections, associated data, expertise and institutional capacities in Montenegro has been initiated as a first step towards developing a coordinated national biobanking network.
Achievements linked to calendar year 2025
Contact
Montenegro node page →
Established in 2008, BBMRI.nl is the Dutch node of BBMRI-ERIC and a partner of Health-RI, the organisation dedicated to improving the reuse of health and life sciences data for policy, research and innovation. Connected through BBMRI.nl, more than 1,000 biobank collections and over 2,000 biobank professionals provide access to high-quality biomaterials and associated data that support basic, translational, clinical and implementation research.
BBMRI.nl strengthens health research in the Netherlands by fostering innovation, harmonisation, connectivity and the sustainable (green) operation of biobanks. More about BBMRI.nl.
Top 3 Areas of expertise
- Promoting harmonisation by further developing and implementing evidence-based procedures, guidelines and standards, aligned with national and international frameworks.
- Providing support by co-developing, implementing, promoting and maintaining services that facilitate the discovery and sharing of biomaterials and associated data for research and innovation.
- Distributing knowledge that adds value to the biobank community through communication channels, stakeholder discussions and the National Biobank Day.
Top 3 Achievements
- Renewing the organisational structure of BBMRI.nl, in close collaboration with the central biobanks of Dutch academic hospitals and Health-RI, responsible for the development of a sustainable, integrated health and life sciences data infrastructure.
- Executing projects aimed at harmonising pre-analytical workflows, biobank consent procedures and the evaluation of existing biobanks, with results shared and aligned at the European level.
- Organising the second National Biobank Day in Nijmegen, bringing together 135 participants to discuss a broad range of biobank-related topics, from bioresources shaping precision medicine to One Health initiatives.
Achievements linked to calendar year 2025
Biobanks in the Directory 69
Search them in the BBMRI-ERIC Directory →
Contact
The Netherlands node page →
Biobank Norway (BN, bbmri.no) is a large-scale national research infrastructure for clinical and population-based biobanks, established in 2011. BN has developed key services and technologies, including implementing automated storage solutions that have enabled the use of biological materials linked to rich research data across numerous Norwegian research environments. BN has facilitated the availability of a range of well described biospecimens and corresponding health related data, including large scale genotyping of 450,000 samples from population studies.
These efforts have contributed to several hundred research projects resulting in a vast number of high-profiled publications. Biobank Norway/NTNU, on behalf of BBMRI-ERIC, coordinates the Horizon Europe project, INTEGRATE Large Medical Cohorts. More about BBMRI.no.
Top 3 Areas of expertise
- Initiating and running population-based and clinical biobanks.
- Digitised biobank data — secure solution for handling of sensitive big data.
- Integrating data from multiple sources, such as national and local registries, electronic health records and population studies, mostly accessed through one national entry point.
Top 3 Achievements
- Nordic Biobank Network funded by NordForsk. The project is led from Biobank Norway and PI Therese Haugdahl Nøst.
- The biobank at the Norwegian Institute of Public Health (NIPH) accredited under the international ISO 20387 standard.
- As part of the Biobank Norway 4 project, we have compiled a cross cohort, population based genotype dataset for over 450,000 Norwegian individuals within a secure processing environment and analytical work is now in progress.
Achievements linked to calendar year 2025
Biobanks in the Directory 13
Search them in the BBMRI-ERIC Directory →
Contact
Norway node page →
The Polish National Node coordinates the activities of the Polish biobanking community and its integration with the European infrastructure. The core BBMRI.pl consortium currently consists of eight biobanking institutions, with many others collaborating under the Polish Biobanking Network. Our National Node is responsible for internal and external communications, maintaining contacts and coordination with BBMRI-ERIC, representing the Polish biobanking community to national and international stakeholders and promoting Polish biobanking experts in the European initiatives and working groups.
Our shared vision is to continue developing and expanding an integrated, sustainable and state-of-the-art biobanking network in Poland. To realise this vision, the biobanking community is committed to enhancing coordination, efficiency, and quality in the management of biobank samples. More about BBMRI.pl.
Top 3 Areas of expertise
- Collaborative biobanking with an expanded research dimension: an ability to bridge biobanking and disease research with the special focus on the new cellular models and digital pathology data acquisition and analysis, specifically tailored for the individual research projects.
- Advisory role for the medical staff on the best practices for collecting and preparing the biological samples for state-of-art biobanking.
- Extensive expertise in quality management in biobanking, aligning its practices with international standards such as ISO 20387. The consortium supports the implementation of robust quality systems across Polish biobanks, offering training, audits and guidance to ensure high-quality, reliable biological samples and data.
Top 3 Achievements
- Organisation of the 2025 BBMRI.pl national scientific conference, bringing together researchers, clinicians and biobank representatives with guest speakers from BBMRI-ERIC. The event facilitated knowledge exchange, strengthened national collaboration and enhanced the visibility and strategic role of BBMRI.pl within the Polish biomedical research infrastructure.
- Publication of chapters in an international monograph entitled “Artificial Intelligence in Biobanking: Ethical, Legal and Societal Challenges” on the ethical and legal aspects of AI in biobanking: “Artificial intelligence and communication with research participants in the process of biobanking human biological material”, „Liability for Damages, AI and Machine Learning for Digital Pathology as New Challenges for Biobanks”.
- Participation in the work of expert group appointed by the Ministry of Health regarding biobanking legislation in Poland.
Achievements linked to calendar year 2025
Biobanks in the Directory 12
Search them in the BBMRI-ERIC Directory →
Contact
Poland node page →
Biobanco.PT is the Portuguese National Node of BBMRI-ERIC, bringing together a nationwide network of biobanks, research institutions, hospitals, universities and associated stakeholders committed to advancing biomedical and health research. Through harmonised practices, quality-driven sample management and adherence to ethical and legal standards, Biobanco.PT facilitates access to high-quality biological samples and associated data, supporting national and international research collaborations.
The node strengthens biobanking capacity in Portugal and promotes responsible use of biological resources for scientific discovery, translational research and healthcare innovation.
Top 3 Areas of expertise
- Human biological sample management and biobanking: Collection, processing, storage, quality management and distribution of biological samples and associated data according to internationally recognised biobanking standards
- Biobank network development and harmonisation: Coordination of a multidisciplinary national network of biobanks and biological resource collections, promoting interoperability, standardisation and alignment with European biobanking frameworks
- Training, knowledge exchange and stakeholder engagement: Organisation of workshops, collaborative initiatives and expert discussions addressing key topics in biobanking, fostering professional development, community engagement and the adoption of best practices across the sector
Top 3 Achievements
- Building a national biobanking community: Over the past years, Biobanco.PT has brought together biobanks and biological resource collections from different fields into a growing national network. This collaborative approach has helped strengthen connections between institutions, encourage the sharing of knowledge and experience and create new opportunities for joint initiatives.
- Establishing Portugal within the European biobanking landscape: A major milestone has been the integration of Portugal into BBMRI-ERIC, providing the national biobanking community with greater visibility and opportunities to engage in European collaborations, share expertise and contribute to the development of biobanking at an international level.
- Promoting knowledge exchange and harmonisation: Biobanco.PT has actively improved dialogue across the national biobanking community through workshops, thematic discussions and collaborative activities focused on topics of common interest. These initiatives have disseminated best practices, increased alignment between institutions and strengthened biobanking expertise across Portugal.
Achievements linked to calendar year 2025
Biobanks in the Directory 1
Search them in the BBMRI-ERIC Directory →
Contact
Portugal node page →
Qatar Biobank (QBB), operating under the Qatar Precision Health Institute (QPHI) and Qatar Foundation, is a national resource advancing health research by collecting biological samples and health information from the population of Qatar. As the designated National Node, the biobank enables groundbreaking studies on diseases prevalent in Qatar and the wider region. By integrating lifestyle, clinical and genetic data, it supports precision medicine, pharmacogenomics and population health research. ISO certifications and CAP accredited processes supports high quality biomedical and translational medicine research in line with the national vision and health strategy of the country.
QBB-QPHI is a unique collaboration between science and society, building knowledge to improve healthcare and create a healthier future for generations to come.
Top 3 Areas of expertise
- Sample and data collection of population and disease cohort participants in underrepresented Qatari/Arab population groups with deep phenotypic data.
- Biobanking sustainability and laboratory automation. Innovation-driven, continuously integrates new technologies to improve sustainability and efficiency. Digital platforms link sample tracking, processing and retrieval, ensuring traceability and efficiency.
- Biobank Quality Management — Establishing robust, ISO 20387 and Qatar Health Research Law–aligned processes for the handling of biological samples and associated data to ensure the highest standards of accuracy, reliability and international credibility in biobanking operations.
Top 3 Achievements
- Continued integration of Qatar Biobank and Qatar Genome under Qatar Precision Health Institute transforms Qatar’s biobanking and genomics ecosystem into a cohesive translational medicine platform, linking population research with clinical practice to deliver precision healthcare.
- Cohort 5-Year Follow-Up Visits. Successfully ramped up Follow-Up Visit 1 and initiated Follow-Up Visit 2 for its participant cohorts, marking a major milestone in long-term population health research. This achievement strengthens the biobank’s ability to generate longitudinal data, track disease progression and provide deeper insights into the impact of genetics, lifestyle, and environment on health outcomes in Qatar.
- Qatar Biobank continues to champion biobanking education by supporting local and international students through structured visits, internships and hands-on training programs in collaboration with leading universities. Our active presence at global biobanking events — such as European Biobanking Week and ISBER 2025 — includes delivering expert presentations, hosting competency-based workshops like Developing a ‘Strong Laboratory Workforce’, and leading roundtable discussions on laboratory validation and verification. Contributing to national knowledge-sharing platforms, including webinar series hosted by the Ministry of Public Health.
Achievements linked to calendar year 2025
Biobanks in the Directory 1
Search them in the BBMRI-ERIC Directory →
Contact
Qatar node page →
The Slovak National Node BBMRI.sk (est. June 2025) is a distributed infrastructure designed to unite biobanks across Slovakia. Starting with six founding member organisations, we envision developing a strong operational framework and expand collaboration within the national biobanking network. We aim to ensure interoperability, improve sample and data quality and create opportunities for joint research. In cooperation with BBMRI-ERIC, we plan to adopt international standards, establish strategic partnerships and contribute to projects that will drive innovation in personalised medicine and translational research.
Top 3 Areas of expertise
- Cancer research: We provide high quality, well characterised biospecimens and data that advance oncology research and support progress in diagnostics, targeted therapies and personalised medicine.
- Rare diseases: Patients with rare disorders are included in the National Registry with clearly defined data. Biobank resources enabled additional diagnostic assessment and improved patient care.
- Liver diseases: We maintain diverse liver disease samples linked with clinical registries, contributing to hepatology research and translating findings into practice.
Top 3 Achievements
- In 2025, BBMRI.sk officially joined BBMRI ERIC, reinforcing Slovakia’s role in the European biobanking landscape and opening new opportunities for international collaboration. This achievement enabled us to engage in strategic discussions shaping biomedical research at the European level.
- We initialised cooperation with National Nodes of major research infrastructures — EATRIS.sk, ELIXIR.sk, and SLOVACRIN — and partnered with the Association for the Protection of Patients’ Rights to ensure ethical and patient-focused practices.
- At the same time, we developed comprehensive documentation to support upcoming biobank initiatives, establishing a solid foundation for operational standards and future projects that will drive innovation in research and improve healthcare outcomes in Slovakia.
Achievements linked to calendar year 2025
Biobanks in the Directory 7
Search them in the BBMRI-ERIC Directory →
Contact
Slovakia node page →
BBMRI.si consists of University of Maribor, University of Ljubljana, University of Primorska, National Institute of Biology, University Medical Centre Maribor and University Clinic Golnik. It is very interdisciplinary in its nature covering medical, biological, biochemical, IKT, legal, ethical and societal aspects. We tightly collaborate with the Slovenian Ministry of Health to prepare a new law on biobanking. Moreover, a tight collaboration with the Slovenian Society of Patient Organisation was established to further enhance our outreach.
We successfully published important research findings in leading scientific journals including Nature Genetics, Nature Chemical Biology, Nature Reviews Chemistry and Proceedings of the National Academy of Sciences U.S.A. We tightly collaborate with Slovenian pharmaceutical companies Krka and Lek.
Top 3 Areas of expertise
- Autoimmune disorders
- Cancer
- Rare diseases
Top 3 Achievements
- Securing a multi-million Euro investment into the Slovenian biobanking research infrastructure.
- Publication of a perspective on chemical stability of lipid nanoparticles in Nature Reviews Chemistry.
- Inclusion of several Slovenian biobanks and their sample collections into Directory.
Achievements linked to calendar year 2025
Biobanks in the Directory 6
Search them in the BBMRI-ERIC Directory →
Contact
Slovenia node page →
The ISCIII Biomodels and Biobanks Platform is a national infrastructure under the Institute of Health Carlos III (ISCIII) and serves as Spain’s BBMRI-ERIC National Node. It currently consists of 42 core units and 30 affiliated units, structured into four scientific-technological HUBs: Biobanks (59 units), Organoids (26 units), Animal Models (28 units) and 3D Printing (24 units).
Operating across 15 Autonomous Communities, P_ISCIII_BB enhances biomedical research by facilitating the collection, handling and supply of biological samples, along with associated clinical data, to support scientific and technological advancements on a national and international level. More about BBMRI.es.
Top 3 Areas of expertise
- Sample access: We streamline international access to high-quality biospecimens through our online form and catalogue. A 2025 upgrade to the OMOP standard and improved collection visualisation ease access.
- Biomodels: Our Animal Model HUB catalogue now holds 800+ entries and our expertise extends to organoids and 3D bioprinting for development, validation and knowledge sharing.
- ELSI: In 2025, our helpdesk experts handled four consultations and co-organised the BBMRI-ERIC Academy ELSI Symposium in Bilbao.
Top 3 Achievements
- Becoming a full member of BBMRI-ERIC: After observing since 2021, Spain achieved full membership in BBMRI-ERIC on 15 September 2025. This milestone underscores our commitment to the European biobanking community, strengthens integration into international infrastructures, enhancing visibility, collaboration and access for Spanish researchers.
- Expanding and consolidating our national network: In 2025, the platform supported 308,724 donors and generated over 1.25 million samples, providing 323,084 samples to research projects. We supported 1,617 national and international projects, highlighting the platform’s role in facilitating sample access across Spain and beyond.
- Advancing scientific output, training, and outreach: Our biobanks contributed to 496 publications, obtained 1 patent, organised 162 training events, participated in 447 courses and 1,299 dissemination activities promoted scientific awareness and biobanking visibility.
Achievements linked to calendar year 2025
Biobanks in the Directory 35
Search them in the BBMRI-ERIC Directory →
Contact
Spain node page →
Biobank Sweden is not a biobank but a national infrastructure for biobanking where healthcare, academia, industry and patient organisations collaborate to attain good healthcare and research. We do this by national coordination of regulatory and operative management including documentation, communication, education, quality management and ELSI-matters.
Biobank Sweden also builds a national biobank registry with several functionalities including consent management for health care samples, finding samples for research and healthcare, management of biobank applications and management of applications for clinical trials that need access to biobank samples. More about BBMRI.se.
Top 3 Areas of expertise
- Regulatory management.
- Operative services for collecting, storing and accessing samples.
- Access to pathology samples.
Top 3 Achievements
- National service catalogue of regional pathology services published on national web page by the Network for study coordinators in clinical pathology.
- Interpretation comments on Swedish biobank legislation published.
- Biobank course produced and published for patient representatives at the EUPATI national platform.
Achievements linked to calendar year 2025
Biobanks in the Directory 53
Search them in the BBMRI-ERIC Directory →
Contact
Sweden node page →
In Switzerland, many biobanks operate with heterogeneous processes, making the usability and comparability of samples challenging. Over the past decade, biobanking practices have greatly evolved, from individual collections of biological material to professional infrastructures. In 2013, the Swiss National Science Foundation launched a competitive call to establish a national biobanking platform, from which the Swiss Biobanking Platform (SBP) was selected by an international panel of experts.
Today, SBP serves as the national coordination platform for human and non-human biobanks, supporting biomedical and biological research by addressing questions around quality, visibility and the interoperability of biobanks and their associated data. More about BBMRI.ch.
Top 3 Areas of expertise
- Quality and Practice Harmonisation: SBP supports biobanks through structured documentation and SBP Labels strategy, promoting compliance with legal, ethical and professional standards, including ISO 20387.
- Interoperability and Visibility: SBP BIMS integrates standardised datasets to support interoperable data management, while NExT increases the access and visibility of biobanks and samples.
- Education: SBP offers a Certificate of Advanced Studies (CAS) in Biobanking to strengthen competencies across key biobanking domains.
Top 3 Achievements
- SBP network expansion: The SBP network continued to grow and reached a significant milestone with the attribution of the 100th SBP Label. This reflects increasing national engagement and a strong commitment from Swiss biobanks to quality, harmonised practices and recognised standards.
- First edition of the CAS: The first edition of the Certificate of Advanced Studies (CAS) in Biobanking was successfully completed, receiving very positive feedback from participants. Building on this success, a second edition was launched in January 2026.
- International collaboration on quality and FAIR data: SBP secured a bilateral grant between Switzerland and the Czech Republic, strengthening collaboration on quality management and FAIR data principles and fostering good biobanking practices at the international level.
Achievements linked to calendar year 2025
Biobanks in the Directory 24
Search them in the BBMRI-ERIC Directory →
Contact
Switzerland node page →
Türkiye holds observer status in BBMRI-ERIC, with BBMRI.tr serving as the National Node since 2014, coordinated by Izmir Biomedicine and Genome Center. BBMRI.tr brings together leading biobanking institutions to map and strengthen biobanking activities across Türkiye and the wider Euro-Mediterranean and MENA regions.
Its mission is to establish a sustainable national biobanking network, develop ethical and legal frameworks, harmonise standards and share best practices. Through standardised procedures, robust IT infrastructures, and quality assurance systems, BBMRI.tr contributes to the pan-European BBMRI-ERIC research infrastructure. More about BBMRI.tr.
Top 3 Areas of expertise
- Establishment, long-term preservation, governance and controlled access sharing of high-quality biospecimen and associated data collections within collaborative research frameworks.
- Development, characterisation, and biobanking of innovative experimental models for cancer and rare disease research in translational and preclinical settings.
- Design, implementation, and sustainability of quality management systems for research biobanking, including ethical, legal, and social (ELSI) compliance frameworks.
Top 3 Achievements
- Significant expansion of the rare disease biospecimen collection. Through systematic patient recruitment and strengthened clinical collaborations, substantially increased its rare disease biospecimen inventory, enhancing national coverage and improving sample diversity for translational research. In 2025, 8,671 new biospecimens from 1,353 rare disease patients, with additional samples obtained from affected family members, spanning undiagnosed and 82 different rare disease groups, representing a 2% increase in the total biobank inventory. ii) Increased research utilisation and project support capacity. In 2025, distributed 841 biospecimens to research teams across 13 national/ international projects, supporting translational and preclinical studies in rare diseases and oncology. This reflects a strong sample-to-project conversion rate and demonstrates the biobank’s active integration into multi-center collaborative research workflows.
- Scientific papers and congress appearances. Several scientific papers have been published in high quality journals and these cover topics such as childhood leukaemia, Missense variants in PKAN; clinical, electrophysiological, and neuroimaging features of BPAN; Biobank contribution to understanding haematological cancers and rare diseases; studies of liver tissue. Congress appearances included: CARE4ARID1B Project and Genomic Findings in Pediatric B-ALL Relapse with Ultra-Rare Extramedullary Eye Involvement.
- Supporting the generation of new knowledge via doctoral and master thesis. Acıbadem University Biobank and I.U. Aziz Sancar Rare Disease Biobank supported studies into: Genetic predisposition to leukemia and lymphoma; COP II Pathway Genes Functional Analyses in Hemolytic Anaemia; Current Molecular and Bioinformatic Approaches for Investigating Genetic Components in Neurodegenerative Diseases Associated with Iron Accumulation in the Brain.
Achievements linked to calendar year 2025
Biobanks in the Directory 3
Search them in the BBMRI-ERIC Directory →
Contact
Türkiye node page →
The Ukrainian Association of Research Biobanks (UARB) is a professional association dedicated to advancing biobanking and strengthening research infrastructure in Ukraine. As a professional network uniting domestic biobanks, research institutions, healthcare providers and international stakeholders, UARB is dedicated to elevating Ukrainian biomedical research to global quality standards.
By fostering cross-border collaboration and robust data sharing, the Association serves as a key bridge connecting Ukrainian researchers with the broader European scientific community. Key priorities for UARB include:
More about bbmri.ua
Top 3 Areas of expertise
- Development of the Ukrainian biobanking community: Fostering connections among Ukrainian human biobanks and research institutions, strengthening professional collaboration and supporting the development of a coordinated national biobanking network
- Harmonisation of biobanking standards, regulatory frameworks and ethical practices: Promoting the harmonisation of procedures and quality standards with European requirements, supporting the development of an appropriate national legislative framework and advancing ethical compliance in biobanking and biomedical research
- European integration and international research collaboration: Connecting Ukrainian research biobanks and research facilities with the European biobanking community and research infrastructures, facilitating international partnerships, knowledge exchange and participation in collaborative research initiatives
Top 3 Achievements
- Establishment of a national professional network: Bringing together stakeholders committed to developing and strengthening the biobanking community in Ukraine
- Engagement with European research infrastructure: Advancing Ukraine’s participation in BBMRI-ERIC activities and strengthening connections between Ukrainian biobanks and the European biobanking community
- Advancement of the national regulatory framework for biobanking: Contributing to the development and adoption of Cabinet of Ministers of Ukraine Resolution No. 999 of 30 August 2024, establishing the Procedure for the Collection, Storage and Use of Human Biological Samples for Research Purposes
Achievements linked to calendar year 2025
Contact
Ukraine node page →
